2010 AHA/ASA 美國卒中或短暫性腦缺血發(fā)作患者卒中二級預(yù)防指南   內(nèi)容預(yù)覽：

    The aim of this statement is to provide clinicians with the most up-to-date evidence-based recommendations for the prevention of ischemic stroke among survivors of ischemic stroke or TIA. A writing committee chair and vice chair were designated by the Stroke Council Manusc**t Oversight Committee. A writing committee roster was developed and approved by the Stroke Council with representatives from neurology, cardiology, radiology, surgery, nursing, pharmacy, and epidemiology/biostatistics. The writing group conducted a comprehensive review and synthesis of the relevant literature. The committee reviewed all compiled reports from computerized searches and conducted additional searches by hand. These searches are available on request. Searches were limited to English-language sources and human subjects. Literature citations were generally restricted to published manusc**ts appearing in journals listed in Index Medicus and reflected literature published as of August 1,2009. Because of the scope and importance of certain ongoing clinical trials and other emerging ***rmation, published abstracts were cited for ***rmational purposes when they were the only published ***rmation available, but recommendations were not based on abstracts alone. The references selected for this document are exclusively for peer-reviewed papers that are representative but not allinclusive, with priority given to references with higher levels of evidence. All members of the committee had frequent opportunities to review drafts of the document and reach a consensus with the final recommendations. Recommendations follow the American Heart Association (AHA) and the American College of Cardiology (ACC) methods of classifying the level of certainty of the treatment effect and the class of evidence

    本聲明旨在為臨床醫(yī)生提供在缺血性卒中或TIA患者中預(yù)防缺血性卒中的最新循證推薦。寫作委員會主席和副主席由卒中委員會著述監(jiān)督委員會 (Stroke Council Manusc**t Oversight Committee)指定，其成員名單由卒中委員會擬定和批準，由來自神經(jīng)病學(xué)、心臟病學(xué)、放射學(xué)、外科學(xué)、護理學(xué)、藥劑學(xué)和流行病學(xué)／生物統(tǒng)計學(xué)等專業(yè) 的代表組成。寫作組對相關(guān)文獻進行了全面的回顧和綜合。委員會回顧了通過計算機檢索和進一步的手工檢索獲得的所有匯編報告。如有需要，可提供這些檢索結(jié) 果。檢索限于以人為對象的英文文獻。文獻引文通常限于醫(yī)學(xué)索引(Index Medicus)列出的雜志于2009年8月1日之前發(fā)表的文獻。鑒于某些正在進行的臨床試驗和其他新信息的重要性，如果摘要是唯一可獲得的公開發(fā)表資 料，亦可出于情報目的予以引用，但不能單獨在摘要基礎(chǔ)上做出推薦。本文所選用的參考文獻均為經(jīng)過同行評議的具有代表性的論文，但并不包括全部文獻，而是優(yōu) 先選取具有更高證據(jù)水平草案，并就最終推薦達成共識。本指南的推薦意見遵循美國心臟協(xié)會和美國心血管病學(xué)學(xué)會關(guān)于療效確切性水平和證據(jù)等級的分類方案。

    1.TIA和缺血性卒中亞型的定義

    2.所有TIA或缺血性卒中患者的危險因素控制

    3.大動脈粥樣硬化患者的干預(yù)方法

    4.心源性栓塞的內(nèi)科治療

    5.非心源性栓塞性卒中或TIA(特別是動脈粥樣硬化性、腔隙性或原因不明性梗死)的抗栓治療

    6.其他特殊病因卒中患者的治療

    7.女性卒中

    8.顱內(nèi)出血后抗凝治療的應(yīng)用

    9 .實施指南的特殊方法以及指南在高危人群中的應(yīng)用

點擊下載***：2010 AHA/ASA 美國卒中或短暫性腦缺血發(fā)作患者卒中二級預(yù)防指南